Shares Jump as Firm Launches CBD Sleep Aid

Shares Jump as Firm Launches CBD Sleep Aid

By: Tomas Ronolski - News

Monday, October 18, 2021

The sleep aid market is nothing to snooze about — projected sales are forecasted to hit $100 billion by 2026. And this firm has its eyes wide open to benefit.

PAO Group, Inc. (OTC Pink: PAOG) launched its first CBD nutraceutical product sleep aid, RelaxRX CBD. Available in 30mg Softgels and in an 1800mg Tincture, the CBD oil is 100% derived from full spectrum whole plant hemp oil with no added chemicals.

The firm has shipped the product to its distribution partner, North American Cannabis Holdings, Inc. (OTC Pink: USMJ), and will soon be available for sale online. PAOG plans to announce its next CBD nutraceutical later this week.

Shares were up in mid-morning trade at $0.0078.


Copyright © 2021 All rights reserved. Republication or redistribution of's content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Improving Air Safety and Disrupting the Air Treatment Industry
Walking the Walk, This Penny Stock Crushing It In 2022
Leading Cannabis Accessory Distributor Announces Q3 Results and Rapid Expansion into California
Most Popular
FREE Newsletter Favorites

Back to Top